Kewaunee Q3 revenue +44% to $67.2M; adj. diluted EPS $1.09 vs $0.85

KEWAUNEE SCIENTIFIC CORP /DE/

2025-Q3 EPS reported $2.20 revenue$163,324,000

GAAP diluted EPS $0.45 vs $0.85; net earnings $1.4M vs $2.5M; includes $2.5M Nu Aire acquisition & integration costs.
Adjusted diluted EPS $1.09; adjusted pre-tax earnings $3.8M (+7.8% YoY); adjusted EBITDA $5.7M vs $4.4M.
Backlog hit record $221.6M vs $152.3M a year ago; Domestic segment sales jumped 63.6%, boosted by Nu Aire.
Completed Nu Aire acquisition on Nov 1, 2024; long-term debt rose to $65.8M from $28.5M to fund deal.
International segment sales flat at $15.2M; customer site delays impacted billings; record backlog in India.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.